The results showed that SFAS-H could increase LVEF and LVFS, improve hypertrophy and necrosis of cardiomyocytes and myocardial fibrosis, and reduce cardiac ANP, BNP, NE, and MDA levels in CHF rats. This evidence concerns the gene NPPA and Myocardial fibrosis.